Who is sponsoring NCT05581277?

NCT05581277 is sponsored by Instituto de Investigación Sanitaria Aragón.

What drugs are being tested in NCT05581277?

Interventions in NCT05581277: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders.

What condition does NCT05581277 study?

NCT05581277 studies Emotional Disorder, Post COVID-19 Condition, Anxiety Disorders, Depressive Disorder.

Is NCT05581277 still recruiting?

NCT05581277 is currently status unknown. Last updated 9 March 2023.

Last reviewed 2023-03-09 · How we verify

NCT05581277

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) in People With Post Covid-19 Condition.

Status unknown NA Last updated 9 March 2023

What this trial tests

NA trial testing Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Emotional Disorder in 60 participants. Status unknown.

Timeline

15 January 2023

Primary endpoint
15 June 2023

30 September 2023

Quick facts

Lead sponsor	Instituto de Investigación Sanitaria Aragón
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	15 January 2023
Primary completion	15 June 2023
Estimated completion	30 September 2023
Sites	2 locations across Spain

Drugs / interventions tested

Unified Protocol for Transdiagnostic Treatment of Emotional Disorders

Conditions studied

Emotional Disorder — all drugs for Emotional Disorder →
Post COVID-19 Condition — all drugs for Post COVID-19 Condition →
Anxiety Disorders — all drugs for Anxiety Disorders →
Depressive Disorder — all drugs for Depressive Disorder →

Sponsor

Instituto de Investigación Sanitaria Aragón — full company profile →

Who can join

18 and older, any sex, with Emotional Disorder or Post COVID-19 Condition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present multiple baseline single case trial will study the efficacy and acceptability of the "Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders" in the treatment of emotional symptomatology and/or emotional disorders in a sample of patients with Post Covid-19 condition.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Preliminary feasibility and clinical utility of the Unified Protocol for the transdiagnostic treatment of emotional disorders in people with long COVID-19 condition: A single case pilot study.
Martínez-Borba V, Peris-Baquero Ó, Prieto-Rollán I, Osma J, et al · · 2025 · cited 1× · PMID 40779512 · DOI 10.1371/journal.pone.0329595
Unified Protocol for the transdiagnostic treatment of emotional disorders in people with post COVID-19 condition: study protocol for a multiple baseline n-of-1 trial.
Martínez-Borba V, Martínez-García L, Peris-Baquero Ó, Osma J, et al · · 2023 · cited 1× · PMID 37920733 · DOI 10.3389/fpsyg.2023.1160692

Verify or expand the search:

Other trials of Unified Protocol for Transdiagnostic Treatment of Emotional Disorders

Trials testing the same drug.

NCT06420674 — Online Prevention of Emotional Disorders in Women Undergoing Fertility Treatments · NA · not yet recruiting
NCT06002087 — Unified Protocol for Transdiagnostic Treatment for Depression and Anxiety in Adults · NA · completed
NCT05357586 — The Pitt Center for Emergency Responder Wellness · NA · completed
NCT04612374 — Exploring the Acceptability and Efficacy of a Transdiagnostic Treatment for Misophonia · NA · completed
NCT04198597 — Exploring Two Treatments for Misophonia · NA · completed

Other recruiting trials for Emotional Disorder

Currently open trials in the same condition.

NCT07325565 — Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer · recruiting
NCT06928480 — Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Peop · NA · recruiting

Other Instituto de Investigación Sanitaria Aragón trials

Trials by the same sponsor.

NCT07070531 — Unified Protocol in Penitentiary Facilities · NA · not yet recruiting
NCT07185412 — Spanish Registry of Redo Procedures Following Pulmonary Vein Ablation by Pulsed Field Ablation Technology: RESET-PFA · not yet recruiting
NCT07321444 — Telerehabilitation in Shoulder Pathology · NA · completed
NCT06547450 — Unified Protocol for Treatment of Emotional Disorders in Brief Groups in Primary Care Services in Spain · NA · not yet recruiting
NCT06928480 — Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Peop · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05581277 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto de Investigación Sanitaria Aragón
Last refreshed: 9 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05581277.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing